Neuraxis Inc (NRXS) Live Share Price, Invest From India

Neuraxis Inc Stock Performance

as on March 18, 2026 at 6:59 am IST

Day's Low
Day's High
$6.86
Day's Price Range
$7.29
$7.04
2.56%
Downside
3.55%
Upside
52 Week's Low
52 Week's High
$1.33
52-Week Price Range
$7.46
$7.04
81.11%
Downside
5.97%
Upside

Neuraxis Inc share price movements today

Previous Close: $7.05
Open: $7.17
Volume: 730.0K
Day's Low - High: $6.86 - $7.29
52 Week Low - High: $1.33 - $7.46

Neuraxis Inc Historical Returns

1 Month Return: + 30.8 %
3 Month Return: + 155.43 %
1 Year Return: + 230.99 %
3 Year Return: 0 %
5 Year Return: 0 %

Neuraxis Inc Stock Fundamentals & Key Indicators

Check Neuraxis Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$66.5M

EPS (TTM)

-0.935

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-7.5M

Revenue (TTM)

3.4M

Profit Margin

-224.24%

Return On Equity TTM

-3071.15%

Neuraxis Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuraxis Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Neuraxis Inc	BUY	$66.5M	NA	NA	-224.24%
Alnylam Pharmaceuticals, Inc.	BUY	$41.6B	119.71%	135.09	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$119.2B	114.71%	30.68	32.94%
Beone Medicines Ltd	NA	$32.8B	NA	115	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.8B	52.6%	17.99	31.41%

Stock Returns calculator for Neuraxis Inc Stock including INR - Dollar returns

The Neuraxis Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Neuraxis Inc investment value today

Current value as on today

₹3,37,055

Returns

₹2,37,055

(+237.06%)

Returns from Neuraxis Inc Stock

₹2,30,516 (+230.52%)

Dollar Returns*

₹6,539 (+6.54%)

Analyst Recommendation on Neuraxis Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Neuraxis Inc. Average target price of $5

Neuraxis Inc Share Price Target

Get share price movements and forecasts by analysts on Neuraxis Inc.

What analysts predicted

-40.8%DOWNSIDE

Target Price

Current Price

$7.04

Analyzed by

7 Analysts

Target

$5.00

Neuraxis Inc target price $5, a slight downside of -40.8% compared to current price of $7.04. According to 7 analysts rating.

Neuraxis Inc Stock’s Investor Sentiment and Interest

Search interest for Neuraxis Inc Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 16, 2026 to March 18, 2026

Change:-25% versus previous 30 day period

Neuraxis Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-1	-3	-1	-1	-2	-1	-1	-2	-1	-2
EBITDA	-1	-7	-1	-2	-2	-1	-1	-2	-1	-2
Interest Expense	1	1	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-8	-5	-2	-2	-1	-1	-2	-1	-2
Income Tax Expense	1	1	0	0	0	-	-	-	-	-
Net Income	-2	-8	-5	-2	-2	-1	-1	-2	-1	-2
Net Profit Margin	-346.06%	-1806.51%	-999.76%	-327.95%	-477.14%	-263.30%	-190.22%	-254.42%	-189.07%	-261.62%

Neuraxis Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	2	2	2	2
Gross Profit	1	2	2	2	2
Operating Income	-4	-2	-3	-6	-7
EBITDA	-3	-2	-4	-9	-7
Interest Expense	0	0	0	5	0
Depreciation	0	0	0	0	0
Income Before Tax	-3	-3	-4	-14	-8
Income Tax Expense	0	0	0	5	-8
Net Income	-3	-3	-4	-14	-8
Net Profit Margin	-193.04%	-111.27%	-178.05%	-594.57%	-306.84%

Neuraxis Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-8	-5	-2	-2	-1	-1	-2	-1	-2
Operating Cash Flow	-2	-2	-1	-1	-1	-1	-1	-1	-1
Investing Cash Flow	0	-	0	0	0	-	0	0	-
Financing Cash Flow	3	1	1	3	0	5	0	5	0
Change in Cash	0	0	0	1	-1	3	-1	3	-1

Neuraxis Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-3	-4	-14	-8
Operating Cash Flow	-2	-2	-6	-6
Investing Cash Flow	0	0	0	0
Financing Cash Flow	0	2	6	9
Change in Cash	-1	0	0	3

Insights on Neuraxis Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NRXS has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 months, NRXS stock has moved up by 155.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -1.69M → -2.12M (in $), with an average decrease of 25.6% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 895.65K → 811.41K (in $), with an average decrease of 4.7% per quarter

About Neuraxis Inc

Neuraxis, Inc. is a medical technology company. The Company is focused on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults. It focuses on advancing science and leveraging evidence-based medicine to drive the adoption of its IB-Stim therapy, which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim is a food and drug administration (FDA) cleared for functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents 11-18 years old. The Company’s second product, the Rectal Expulsion Device (RED), is indicated to evaluate the neuromuscular function of a patient’s ability to expel its contents from the rectum and as a qualitative test for rectal hypersensitivity. RED (K242304, 2024) helps identify patients with rectal hypersensitivity who experience a desire or urge defecating at lower volumes of distension.

Organisation	Neuraxis Inc
Headquarters	11611 North Meridian St, Carmel, IN, United States, 46032
CEO	Mr. Brian Carrico
E-voting on shares	Click here to vote

Key Management of Neuraxis Inc

Name	Title
Mr. Timothy Robert Henrichs	Chief Financial Officer
Dr. Adrian Miranda	Senior VP of Science & Technology and Chief Medical Officer
Dr. Thomas Carrico	Chief Regulatory Officer and Compliance & Privacy Officer
Dr. Christopher Robin Brown D.D.S.	Founder, Director of Innovation & Director
Mr. Behnam Shamsian CPA	Investor Relations
Mr. Brian Carrico	President, CEO & Director

FAQs

What is Neuraxis Inc share price today?

Neuraxis Inc share price today is $7.04 as on March 18, 2026 at 1:29 am IST at the close of the market. Neuraxis Inc share today touched a day high of $7.29 and a low of $6.86.

What is the 52 week high and 52 week low for Neuraxis Inc share?

Neuraxis Inc share touched a 52 week high of $7.46 on March 16, 2026 and a 52 week low of $1.33 on April 16, 2025. Neuraxis Inc stock price today i.e. March 18, 2026 at 1:29 am IST is closed at $7.04,which is 5.63% down from its 52 week high and 429.32% up from its 52 week low.

What is Neuraxis Inc's market capitalisation today?

Neuraxis Inc market capitalisation is $0.00T as on March 18, 2026 at 1:29 am IST.

How to invest in Neuraxis Inc Stock (NRXS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neuraxis Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neuraxis Inc Shares that will get you 0.2131 shares as per Neuraxis Inc share price of $7.04 per share as on March 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Neuraxis Inc Stock (NRXS) from India?

Indian investors can start investing in Neuraxis Inc (NRXS) shares with as little as ₹92.369 or $1 (as of March 18, 2026 at 3:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹923.69 in Neuraxis Inc stock (as per the Rupee-Dollar exchange rate as on March 18, 2026 at 3:43 am IST). Based on Neuraxis Inc share’s latest price of $7.04 as on March 18, 2026 at 1:29 am IST, you will get 1.4205 shares of Neuraxis Inc. Learn more about fractional shares .